Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free IMAX Stock Alerts

IMAX (IMAX) Financials

IMAX logo
$51.25 +0.87 (+1.73%)
As of 08/31/2026 03:58 PM Eastern
Compare
Annual Income Statements for IMAX

Annual Income Statements for IMAX

This table shows IMAX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 56 29 2.34 23 47 -144 -22 -23 25 26 35
Consolidated Net Income / (Loss)		 65 39 13 34 59 -157 -9.58 -20 33 33 46
Net Income / (Loss) Continuing Operations		 65 39 13 34 59 -157 -9.58 -20 33 33 46
Total Pre-Tax Income 		87 58 30 44 75 -129 11 -9.77 46 38 63
Total Operating Income		 88 59 31 45 77 -122 11 -4.83 50 44 84
Total Gross Profit		 219 203 185 205 212 2.33 134 156 214 190 246
Total Revenue		 374 377 381 374 396 137 255 301 375 352 410
Operating Revenue		 374 377 381 374 396 137 255 301 375 352 410
Total Cost of Revenue		 155 175 196 170 184 135 117 144 160 162 164
Operating Cost of Revenue		 155 175 196 166 181 116 120 144 160 162 164
Total Operating Expenses		 132 144 154 160 134 125 127 161 164 146 162
Selling, General & Admin Expense		 115 124 110 117 123 108 117 138 144 133 138
Research & Development Expense		 13 16 21 14 5.20 5.62 6.94 5.30 10 5.10 5.82
Amortization Expense		 1.86 2.08 3.02 4.15 4.96 5.39 4.88 4.83 4.58 5.76 7.52
Other Operating Expenses / (Income)		 0.75 0.95 2.65 2.99 - - - 8.55 1.76 -0.97 0.70
Impairment Charge		 0.83 0.42 1.23 0.00 0.00 1.15 0.00 4.47 0.14 0.00 7.00
Restructuring Charge		 0.00 0.00 16 9.54 0.85 0.00 0.00 0.00 2.95 3.75 2.48
Total Other Income / (Expense), net		 -0.69 -0.74 -1.43 -1.57 -1.94 -6.70 0.00 -4.94 -4.28 -6.16 -21
Interest Expense		 1.66 2.23 1.94 2.92 3.53 7.01 7.09 6.43 7.23 8.47 23
Interest & Investment Income		 - - 1.03 1.84 1.59 0.31 7.56 1.50 2.95 2.31 1.93
Income Tax Expense		 20 16 17 9.52 17 27 21 10 13 5.00 18
Net Income / (Loss) Attributable to Noncontrolling Interest		 8.78 11 10 11 12 -14 13 2.92 7.73 6.64 11
Basic Earnings per Share		 $0.79 $0.43 $0.04 $0.36 $0.76 ($2.43) ($0.38) ($0.40) $0.47 $0.49 $0.65
Weighted Average Basic Shares Outstanding		 70.70M 66.90M 58.60M 61.48M 61.36M 59.24M 59.13M 56.67M 54.31M 52.65M 53.64M
Diluted Earnings per Share		 $0.78 $0.42 $0.04 $0.36 $0.76 ($2.43) ($0.38) ($0.40) $0.46 $0.48 $0.63
Weighted Average Diluted Shares Outstanding		 70.70M 66.90M 58.60M 61.48M 61.36M 59.24M 59.13M 56.67M 55.15M 53.86M 55.54M
Weighted Average Basic & Diluted Shares Outstanding		 70.70M 66.90M 58.60M 61.48M 61.36M 58.95M 58.58M 53.97M 52.95M 53.02M 53.99M

Quarterly Income Statements for IMAX

This table shows IMAX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 2.54 3.27 3.58 14 5.31 2.33 11 21 0.64 4.23 15
Consolidated Net Income / (Loss)		 3.31 5.42 5.07 15 6.87 8.15 12 23 2.53 6.07 16
Net Income / (Loss) Continuing Operations		 3.31 5.42 5.07 15 6.87 8.15 12 23 2.53 6.07 16
Total Pre-Tax Income 		1.46 11 1.08 18 8.32 15 13 28 6.60 8.49 19
Total Operating Income		 2.74 12 2.87 19 9.51 17 14 29 24 9.95 21
Total Gross Profit		 44 47 44 51 48 53 54 67 72 46 63
Total Revenue		 86 79 89 91 93 87 92 107 125 81 103
Operating Revenue		 86 79 89 91 93 87 92 107 125 81 103
Total Cost of Revenue		 42 32 45 40 44 33 38 39 53 36 40
Operating Cost of Revenue		 42 32 45 40 44 33 38 39 53 36 40
Total Operating Expenses		 41 35 41 32 39 36 39 38 48 36 42
Selling, General & Admin Expense		 35 31 38 31 32 33 35 34 35 32 35
Research & Development Expense		 2.72 2.19 2.03 -0.27 1.15 1.32 1.54 1.51 1.45 1.80 1.66
Amortization Expense		 1.25 1.34 1.32 1.54 1.55 1.73 1.81 1.91 2.07 2.03 2.16
Other Operating Expenses / (Income)		 - - 0.14 -1.14 - -0.13 -0.18 0.60 - -0.46 1.48
Restructuring Charge		 1.59 0.00 0.00 0.00 3.75 0.06 0.79 0.00 1.64 0.00 2.29
Total Other Income / (Expense), net		 -1.28 -1.49 -1.80 -1.69 -1.19 -1.30 -0.91 -1.22 -18 -1.46 -1.36
Interest Expense		 2.03 1.95 2.39 2.35 1.90 1.80 2.06 1.82 17 1.90 2.03
Interest & Investment Income		 0.68 0.56 0.59 0.66 0.49 0.57 1.15 0.59 -0.38 0.50 0.67
Income Tax Expense		 -1.85 5.16 -4.00 2.38 1.46 7.29 1.20 5.21 4.08 2.42 3.51
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.77 2.15 1.49 1.45 1.56 5.82 0.98 1.96 1.89 1.85 0.51
Basic Earnings per Share		 $0.05 $0.06 $0.07 $0.26 $0.10 $0.04 $0.21 $0.38 $0.02 $0.08 $0.28
Weighted Average Basic Shares Outstanding		 54.31M 52.50M 52.63M 52.68M 52.65M 53.15M 53.75M 53.79M 53.64M 54.13M 54.95M
Diluted Earnings per Share		 $0.05 $0.06 $0.07 $0.26 $0.09 $0.04 $0.20 $0.37 $0.02 $0.07 $0.27
Weighted Average Diluted Shares Outstanding		 55.15M 53.41M 53.43M 54.09M 53.86M 54.97M 55.16M 55.57M 55.54M 56.39M 56.57M
Weighted Average Basic & Diluted Shares Outstanding		 52.95M 52.62M 52.68M 52.68M 53.02M 53.74M 53.78M 53.80M 53.99M 54.86M 54.84M

Annual Cash Flow Statements for IMAX

This table details how cash moves in and out of IMAX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 211 -113 -46 -17 -32 208 -128 -92 -21 24 51
Net Cash From Operating Activities		 84 78 85 110 90 -23 6.07 17 59 71 127
Net Cash From Continuing Operating Activities		 114 122 85 110 90 -23 6.07 17 59 71 127
Net Income / (Loss) Continuing Operations		 65 39 13 34 59 -157 -9.58 -20 33 33 46
Consolidated Net Income / (Loss)		 65 39 13 34 59 -157 -9.58 -20 33 33 46
Depreciation Expense		 43 46 67 57 63 53 56 57 60 66 62
Amortization Expense		 - - - - 0.51 0.90 2.51 3.18 2.24 1.97 1.98
Non-Cash Adjustments To Reconcile Net Income		 31 41 54 23 33 61 19 44 27 23 53
Changes in Operating Assets and Liabilities, net		 -54 -49 -48 -3.65 -65 20 -62 -67 -64 -53 -36
Net Cash From Investing Activities		 -79 -65 -74 -57 -66 -9.26 -0.01 -53 -32 -41 -42
Net Cash From Continuing Investing Activities		 -79 -65 -74 -57 -66 -9.26 -0.01 -53 -32 -41 -42
Purchase of Property, Plant & Equipment		 -43 -15 -24 -13 -7.42 -0.70 -3.59 -8.42 -6.49 -8.43 -8.17
Acquisitions		 -7.07 -6.70 -5.21 -8.70 -2.93 -1.90 -4.09 -20 -8.34 -8.45 -5.32
Sale and/or Maturity of Investments		 - - - - -15 0.00 18 0.00 1.05 0.00 0.00
Other Investing Activities, net		 -28 -43 -43 -35 -40 -6.65 -10 -25 -18 -24 -28
Net Cash From Financing Activities		 205 -126 -58 -71 -57 241 -133 -59 -49 -6.04 -34
Net Cash From Continuing Financing Activities		 205 -126 -58 -71 -57 241 -133 -59 -49 -6.04 -34
Repayment of Debt		 -12 -20 -2.00 -53 -55 -1.07 -309 -5.88 -53 -43 -112
Repurchase of Preferred Equity		 - -117 -5.13 -0.92 -14 -3.09 - - - - -275
Repurchase of Common Equity		 -51 -2.00 -46 -71 -22 -38 -24 -83 -27 -18 -1.45
Payment of Dividends		 -9.51 0.00 0.00 -6.93 -4.38 -4.21 -4.89 -2.70 -1.44 0.00 0.00
Issuance of Debt		 25 0.00 0.00 65 35 288 227 38 40 55 352
Other Financing Activities, net		 33 10 -4.26 -12 1.81 -0.51 -22 -4.64 -6.95 -0.20 3.09

Quarterly Cash Flow Statements for IMAX

This table details how cash moves in and out of IMAX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -33 4.82 11 13 -3.91 -3.52 12 34 8.06 -5.17 14
Net Cash From Operating Activities		 4.01 -11 35 35 11 6.95 23 68 29 4.03 32
Net Cash From Continuing Operating Activities		 4.01 -11 35 35 11 6.95 23 68 29 4.03 32
Net Income / (Loss) Continuing Operations		 3.31 5.42 5.07 15 6.87 8.15 12 23 2.53 6.07 16
Consolidated Net Income / (Loss)		 3.31 5.42 5.07 15 6.87 8.15 12 23 2.53 6.07 16
Depreciation Expense		 14 15 19 15 17 15 16 16 16 15 16
Amortization Expense		 0.49 0.49 0.49 0.49 0.49 0.49 0.49 0.51 0.49 0.53 0.53
Non-Cash Adjustments To Reconcile Net Income		 7.29 4.93 9.39 4.40 4.60 4.57 7.56 7.21 32 -3.24 9.90
Changes in Operating Assets and Liabilities, net		 -21 -37 1.25 0.15 -17 -21 -13 22 -22 -15 -10
Net Cash From Investing Activities		 -13 -7.14 -8.50 -15 -11 -15 -7.42 -13 -7.14 -6.93 -6.10
Net Cash From Continuing Investing Activities		 -13 -7.14 -8.50 -15 -11 -15 -7.42 -13 -7.14 -6.93 -6.10
Purchase of Property, Plant & Equipment		 -3.95 -1.10 -1.59 -1.13 -4.61 -1.65 -2.36 -2.74 -1.42 -2.13 -0.02
Acquisitions		 -2.93 -1.59 -1.60 -1.61 -3.65 -1.23 -2.14 -0.54 -1.41 -0.79 -1.36
Other Investing Activities, net		 -7.30 -4.44 -5.32 -12 -2.61 -12 -2.92 -9.45 -4.31 -4.00 -4.72
Net Cash From Financing Activities		 -24 23 -16 -7.56 -5.09 4.23 -3.75 -21 -14 -2.76 -12
Net Cash From Continuing Financing Activities		 -24 23 -16 -7.56 -5.09 4.23 -3.75 -21 -14 -2.76 -12
Repayment of Debt		 -10 -0.16 -21 -11 -10 -10 -8.16 -77 -17 -20 -16
Issuance of Debt		 8.69 45 6.00 4.00 - 23 6.00 56 267 31 7.00
Other Financing Activities, net		 -0.01 -4.19 -0.78 -0.38 5.16 -8.56 -0.14 0.35 11 -14 11

Annual Balance Sheets for IMAX

This table presents IMAX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 931 857 867 874 889 998 883 821 815 830 894
Total Current Assets		 578 472 457 290 390 555 480 407 256 254 307
Cash & Equivalents		 317 205 159 142 109 317 190 97 76 101 151
Accounts Receivable		 215 218 260 93 100 56 110 136 136 108 108
Inventories, net		 39 42 31 45 43 40 27 32 32 33 33
Prepaid Expenses		 6.50 6.63 7.55 10 10 10 12 12 12 13 15
Plant, Property, & Equipment, net		 218 245 277 281 307 277 260 253 243 240 243
Total Noncurrent Assets		 134 140 133 303 192 165 143 161 315 336 344
Noncurrent Note & Lease Receivables		 - - - 127 40 41 44 44 191 202 213
Goodwill		 39 39 39 39 39 39 39 53 53 53 46
Intangible Assets		 29 30 31 34 30 26 23 33 35 35 32
Noncurrent Deferred & Refundable Income Taxes		 26 21 31 31 24 18 14 9.90 7.99 14 13
Other Noncurrent Operating Assets		 41 50 32 70 43 27 22 21 28 31 40
Total Liabilities & Shareholders' Equity		 931 857 867 874 889 998 883 821 815 830 894
Total Liabilities		 253 231 263 274 246 533 453 491 469 452 466
Total Current Liabilities		 224 203 238 130 133 208 128 143 137 121 175
Accounts Payable		 23 20 24 32 20 21 16 25 26 20 19
Accrued Expenses		 96 93 100 98 113 99 112 117 111 101 105
Current Deferred Revenue		 105 90 113 - - 88 - - - - 50
Total Noncurrent Liabilities		 29 27 25 144 113 325 325 349 332 331 291
Long-Term Debt		 29 27 25 38 18 306 226 263 252 266 279
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - 0.00 19 18 15 13 13 13
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - - 0.00
Redeemable Noncontrolling Interest		 3.31 4.98 1.35 6.44 5.91 0.76 0.76 0.72 0.66 0.68 0.67
Total Equity & Noncontrolling Interests		 674 622 602 593 637 464 430 329 345 378 427
Total Preferred & Common Equity		 624 562 528 512 548 394 356 263 273 299 338
Total Common Equity		 624 562 528 512 548 394 356 263 273 299 338
Common Stock		 611 617 621 602 595 596 585 562 574 587 584
Retained Earnings		 20 -47 -88 -85 -40 -203 -235 -293 -293 -275 -240
Accumulated Other Comprehensive Income / (Loss)		 -7.44 -5.20 -0.63 -3.59 -3.19 0.99 2.53 -9.85 -12 -17 -10
Other Equity Adjustments		 - - - - - 0.00 3.93 3.93 3.93 4.05 4.22
Noncontrolling Interest		 50 60 75 81 89 70 74 66 72 78 89

Quarterly Balance Sheets for IMAX

This table presents IMAX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 822 816 851 824 827 848 848 869 890 893 918
Total Current Assets		 406 396 429 396 263 270 265 286 308 307 328
Cash & Equivalents		 99 95 110 81 92 105 97 109 143 146 160
Accounts Receivable		 123 126 136 141 122 114 122 127 108 109 115
Inventories, net		 37 37 45 36 38 38 32 37 41 36 39
Prepaid Expenses		 14 12 13 13 12 13 14 13 15 17 14
Plant, Property, & Equipment, net		 248 239 238 240 238 245 245 244 244 241 239
Total Noncurrent Assets		 168 181 184 188 327 333 338 339 338 345 351
Noncurrent Note & Lease Receivables		 47 57 59 65 193 198 203 204 203 212 216
Goodwill		 53 53 53 53 53 53 53 53 53 46 46
Intangible Assets		 33 34 34 35 35 34 35 34 33 31 30
Noncurrent Deferred & Refundable Income Taxes		 11 11 12 7.71 16 16 14 14 13 13 12
Other Noncurrent Operating Assets		 22 24 25 28 30 32 33 34 36 44 47
Total Liabilities & Shareholders' Equity		 822 816 851 824 827 848 848 869 890 893 918
Total Liabilities		 488 478 494 491 484 480 464 464 453 465 467
Total Current Liabilities		 213 141 228 120 189 191 118 117 183 161 172
Accounts Payable		 26 24 38 19 20 26 25 32 22 17 23
Accrued Expenses		 114 117 124 101 106 111 93 85 96 88 97
Current Deferred Revenue		 74 - 66 - 63 54 - - 65 56 53
Total Noncurrent Liabilities		 275 337 266 371 295 289 346 346 270 303 295
Long-Term Debt		 259 256 252 297 283 276 280 278 257 291 283
Noncurrent Deferred & Payable Income Tax Liabilities		 16 14 13 13 13 13 13 13 13 13 13
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 0.73 0.73 0.66 0.65 0.66 0.67 0.68 0.69 0.72 0.69 0.72
Total Equity & Noncontrolling Interests		 333 337 357 333 342 367 384 404 436 428 450
Total Preferred & Common Equity		 264 271 287 259 267 289 300 320 350 335 356
Total Common Equity		 264 271 287 259 267 289 300 320 350 335 356
Common Stock		 560 566 570 565 571 577 584 591 598 576 590
Retained Earnings		 -292 -284 -272 -297 -294 -280 -272 -261 -241 -236 -231
Accumulated Other Comprehensive Income / (Loss)		 -7.88 -15 -15 -13 -14 -11 -16 -14 -12 -8.66 -7.05
Other Equity Adjustments		 3.93 3.93 3.93 3.93 3.93 3.93 4.11 4.22 4.22 4.22 4.22
Noncontrolling Interest		 69 66 70 74 75 78 84 84 86 92 94

Annual Metrics And Ratios for IMAX

This table displays calculated financial ratios and metrics derived from IMAX's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 28.66% 0.94% 0.91% -1.67% 5.68% -65.37% 86.04% 18.02% 24.61% -6.04% 16.47%
EBITDA Growth		 42.93% -18.98% -8.29% 4.48% 37.85% -148.46% 201.32% -20.42% 104.81% -1.17% 33.53%
EBIT Growth		 52.28% -32.29% -48.53% 44.46% 72.97% -257.64% 108.64% -145.95% 1,142.57% -12.97% 92.03%
NOPAT Growth		 56.12% -37.57% -67.16% 154.94% 70.12% -241.94% 88.77% 64.66% 1,167.90% 5.30% 59.23%
Net Income Growth		 53.25% -39.16% -68.16% 168.37% 74.34% -368.88% 93.92% -107.55% 266.35% -1.10% 39.21%
EPS Growth		 39.29% -46.15% -90.48% 800.00% 111.11% -419.74% 84.36% -5.26% 215.00% 4.35% 31.25%
Operating Cash Flow Growth		 -3.11% -7.52% 9.62% 28.82% -17.82% -125.46% 126.36% 185.59% 238.40% 20.85% 79.38%
Free Cash Flow Firm Growth		 -58.79% -617.39% 59.45% 251.94% 66.57% -37.85% -412.95% 10.55% 128.22% 72.59% 215.69%
Invested Capital Growth		 19.73% 15.46% 4.71% 5.16% 8.42% -18.04% 5.98% 6.16% 5.48% 4.30% 2.08%
Revenue Q/Q Growth		 4.73% -3.19% 5.15% -4.24% 4.03% -33.26% 25.99% -3.38% -3.11% 1.93% 8.61%
EBITDA Q/Q Growth		 4.93% -12.39% 24.59% -24.17% 23.62% -180.35% 171.16% -26.33% -4.63% 9.68% 10.42%
EBIT Q/Q Growth		 5.20% -20.78% 17.27% -31.94% 46.03% -47.65% 136.10% -136.45% -8.69% 18.26% 20.95%
NOPAT Q/Q Growth		 7.04% -26.04% -20.73% -28.70% 76.33% -47.65% 53.07% 79.11% -1.80% 8.53% 13.43%
Net Income Q/Q Growth		 6.13% -26.49% -21.25% -12.79% 42.89% -35.08% 77.47% -87.89% -2.28% 12.20% -8.71%
EPS Q/Q Growth		 4.00% -31.15% -55.56% -12.20% 52.00% -37.29% 58.70% -48.15% 2.22% 9.09% -10.00%
Operating Cash Flow Q/Q Growth		 47.58% -10.99% -11.07% 22.17% -17.21% -198.88% 151.51% -33.71% -17.96% 11.80% 16.39%
Free Cash Flow Firm Q/Q Growth		 108.28% -190.69% -21.43% 160.36% 297.25% 23.67% -209.14% 10.85% -41.68% 459.80% 16.94%
Invested Capital Q/Q Growth		 -2.64% 2.83% 2.18% -2.18% 0.23% -6.09% 1.43% 3.23% 4.26% 0.80% 0.79%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 58.66% 53.71% 48.65% 54.70% 53.52% 1.70% 52.73% 51.98% 57.18% 54.00% 60.02%
EBITDA Margin		 35.19% 28.24% 25.67% 27.27% 35.58% -49.79% 27.12% 18.29% 30.05% 31.61% 36.24%
Operating Margin		 23.48% 15.53% 8.26% 12.07% 19.53% -88.92% 4.31% -1.61% 13.45% 12.45% 20.53%
EBIT Margin		 23.74% 15.92% 8.12% 11.93% 19.53% -88.92% 4.13% -1.61% 13.45% 12.45% 20.53%
Profit (Net Income) Margin		 17.29% 10.42% 3.29% 8.97% 14.80% -114.95% -3.76% -6.61% 8.82% 9.28% 11.10%
Tax Burden Percent		 74.21% 67.97% 41.71% 77.04% 77.75% 121.96% -87.17% 203.47% 71.70% 86.75% 71.93%
Interest Burden Percent		 98.13% 96.28% 97.04% 97.60% 97.49% 105.99% 104.43% 202.09% 91.51% 85.95% 75.14%
Effective Tax Rate		 23.03% 28.02% 55.95% 21.83% 22.26% 0.00% 187.17% 0.00% 28.30% 13.25% 28.07%
Return on Invested Capital (ROIC)		 18.93% 10.06% 3.01% 7.32% 11.66% -17.48% -2.12% -0.70% 7.11% 7.14% 11.02%
ROIC Less NNEP Spread (ROIC-NNEP)		 20.43% 11.29% 3.87% 8.77% 13.08% 91.70% -2.17% -17.21% 5.31% 4.01% 0.75%
Return on Net Nonoperating Assets (RNNOA)		 -7.22% -4.03% -0.98% -1.74% -2.23% -10.95% -0.02% -4.52% 2.68% 1.89% 0.27%
Return on Equity (ROE)		 11.71% 6.03% 2.04% 5.59% 9.43% -28.43% -2.14% -5.23% 9.79% 9.04% 11.30%
Cash Return on Invested Capital (CROIC)		 0.97% -4.28% -1.58% 2.29% 3.57% 2.35% -7.92% -6.68% 1.78% 2.93% 8.97%
Operating Return on Assets (OROA)		 11.43% 6.72% 3.59% 5.13% 8.77% -12.91% 1.12% -0.57% 6.16% 5.33% 9.77%
Return on Assets (ROA)		 8.33% 4.40% 1.45% 3.86% 6.65% -16.69% -1.02% -2.33% 4.04% 3.98% 5.28%
Return on Common Equity (ROCE)		 10.68% 5.49% 1.80% 4.83% 8.04% -24.17% -1.79% -4.26% 7.78% 7.15% 8.93%
Return on Equity Simple (ROE_SIMPLE)		 10.36% 7.00% 2.37% 6.56% 10.69% -39.97% -2.69% -7.55% 12.11% 10.92% 0.00%
Net Operating Profit after Tax (NOPAT)		 68 42 14 35 60 -85 -9.57 -3.38 36 38 61
NOPAT Margin		 18.07% 11.18% 3.64% 9.43% 15.18% -62.24% -3.76% -1.12% 9.64% 10.80% 14.77%
Net Nonoperating Expense Percent (NNEP)		 -1.51% -1.23% -0.86% -1.44% -1.42% -109.18% 0.05% 16.50% 1.80% 3.13% 10.28%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -0.57% 6.05% 5.91% 8.59%
Cost of Revenue to Revenue		 41.34% 46.29% 51.35% 45.30% 46.48% 98.30% 45.72% 48.02% 42.82% 46.00% 39.98%
SG&A Expenses to Revenue		 30.86% 32.95% 28.86% 31.38% 31.20% 79.18% 46.03% 45.89% 38.52% 37.68% 33.75%
R&D to Revenue		 3.41% 4.32% 5.48% 3.67% 1.32% 4.10% 2.72% 1.76% 2.70% 1.45% 1.42%
Operating Expenses to Revenue		 35.18% 38.18% 40.39% 42.63% 33.98% 91.06% 49.97% 53.59% 43.74% 41.55% 39.48%
Earnings before Interest and Taxes (EBIT)		 89 60 31 45 77 -122 11 -4.83 50 44 84
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 132 107 98 102 141 -68 69 55 113 111 149
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.94 3.73 2.84 2.30 2.29 2.69 2.96 3.12 3.00 4.50 5.88
Price to Tangible Book Value (P/TBV)		 4.42 4.26 3.28 2.68 2.62 3.23 3.59 4.62 4.43 6.38 7.66
Price to Revenue (P/Rev)		 6.58 5.56 3.94 3.14 3.16 7.74 4.14 2.73 2.19 3.83 4.85
Price to Earnings (P/E)		 44.04 72.88 639.54 51.53 26.72 0.00 0.00 0.00 32.37 51.75 57.01
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 2.27% 1.37% 0.16% 1.94% 3.74% 0.00% 0.00% 0.00% 3.09% 1.93% 1.75%
Enterprise Value to Invested Capital (EV/IC)		 5.72 4.42 3.07 2.34 2.31 2.52 2.50 2.13 2.05 2.93 3.97
Enterprise Value to Revenue (EV/Rev)		 5.95 5.26 3.79 3.10 3.14 8.07 4.57 3.50 2.85 4.52 5.38
Enterprise Value to EBITDA (EV/EBITDA)		 16.91 18.63 14.75 11.36 8.81 0.00 16.84 19.12 9.48 14.31 14.84
Enterprise Value to EBIT (EV/EBIT)		 25.07 33.04 46.61 25.95 16.05 0.00 110.60 0.00 21.20 36.32 26.19
Enterprise Value to NOPAT (EV/NOPAT)		 32.92 47.07 104.07 32.83 20.65 0.00 0.00 0.00 29.57 41.87 36.41
Enterprise Value to Operating Cash Flow (EV/OCF)		 26.41 25.49 16.89 10.54 13.73 0.00 191.86 60.71 18.23 22.49 17.36
Enterprise Value to Free Cash Flow (EV/FCFF)		 641.10 0.00 0.00 104.85 67.35 96.61 0.00 0.00 118.11 102.04 44.75
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.04 0.04 0.04 0.06 0.03 0.66 0.53 0.80 0.73 0.70 0.65
Long-Term Debt to Equity		 0.04 0.04 0.04 0.06 0.03 0.66 0.53 0.80 0.73 0.70 0.65
Financial Leverage		 -0.35 -0.36 -0.25 -0.20 -0.17 -0.12 0.01 0.26 0.50 0.47 0.36
Leverage Ratio		 1.41 1.37 1.40 1.45 1.42 1.70 2.10 2.24 2.42 2.27 2.14
Compound Leverage Factor		 1.38 1.32 1.36 1.41 1.38 1.81 2.19 4.53 2.22 1.95 1.61
Debt to Total Capital		 4.14% 4.18% 4.03% 5.93% 2.76% 39.68% 34.44% 44.37% 42.17% 41.31% 39.44%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 4.14% 4.18% 4.03% 5.93% 2.76% 39.68% 34.44% 44.37% 42.17% 41.31% 39.44%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 7.54% 9.87% 12.06% 13.69% 14.43% 9.18% 11.32% 11.20% 12.12% 12.22% 12.72%
Common Equity to Total Capital		 88.32% 85.95% 83.91% 80.39% 82.82% 51.14% 54.24% 44.43% 45.70% 46.47% 47.84%
Debt to EBITDA		 0.22 0.26 0.26 0.37 0.13 -4.48 3.27 4.78 2.24 2.39 1.87
Net Debt to EBITDA		 -2.19 -1.67 -1.36 -1.03 -0.76 0.37 0.51 2.99 1.56 1.49 0.86
Long-Term Debt to EBITDA		 0.22 0.26 0.26 0.37 0.13 -4.48 3.27 4.78 2.24 2.39 1.87
Debt to NOPAT		 0.43 0.65 1.83 1.07 0.30 -3.58 -23.62 -77.73 6.98 7.00 4.60
Net Debt to NOPAT		 -4.27 -4.21 -9.63 -2.97 -1.78 0.30 -3.69 -48.64 4.87 4.35 2.10
Long-Term Debt to NOPAT		 0.43 0.65 1.83 1.07 0.30 -3.58 -23.62 -77.73 6.98 7.00 4.60
Altman Z-Score		 7.02 6.42 4.14 3.26 4.07 1.06 1.83 1.24 1.39 2.04 3.13
Noncontrolling Interest Sharing Ratio		 8.80% 9.04% 11.41% 13.55% 14.70% 15.00% 16.20% 18.51% 20.56% 20.89% 20.92%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.58 2.32 1.92 2.23 2.93 2.67 3.75 2.85 1.87 1.47 1.75
Quick Ratio		 2.38 2.08 1.76 1.81 2.53 2.43 3.45 2.55 1.55 1.20 1.48
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 3.47 -18 -7.28 11 18 11 -36 -32 9.05 16 49
Operating Cash Flow to CapEx		 194.66% 509.70% 353.58% 822.65% 1,217.84% -3,301.43% 168.94% 205.61% 903.02% 840.50% 1,555.87%
Free Cash Flow to Firm to Interest Expense		 2.09 -8.04 -3.75 3.79 5.22 1.63 -5.05 -4.98 1.25 1.84 2.16
Operating Cash Flow to Interest Expense		 50.70 34.86 43.96 37.71 25.60 -3.28 0.86 2.69 8.11 8.36 5.56
Operating Cash Flow Less CapEx to Interest Expense		 24.65 28.02 31.53 33.13 23.50 -3.38 0.35 1.38 7.21 7.37 5.20
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.48 0.42 0.44 0.43 0.45 0.15 0.27 0.35 0.46 0.43 0.48
Accounts Receivable Turnover		 1.88 1.74 1.59 2.12 4.10 1.76 3.06 2.44 2.75 2.89 3.80
Inventory Turnover		 5.54 4.32 5.36 4.50 4.20 3.26 3.50 4.94 5.09 5.03 5.02
Fixed Asset Turnover		 1.86 1.63 1.46 1.34 1.35 0.47 0.95 1.17 1.51 1.46 1.70
Accounts Payable Turnover		 6.23 8.04 8.84 6.03 7.01 6.53 6.34 7.02 6.22 7.02 8.35
Days Sales Outstanding (DSO)		 193.81 209.76 229.35 172.24 88.94 207.56 119.11 149.37 132.63 126.39 95.98
Days Inventory Outstanding (DIO)		 65.92 84.51 68.05 81.08 86.87 111.89 104.16 73.86 71.77 72.57 72.71
Days Payable Outstanding (DPO)		 58.58 45.40 41.28 60.57 52.07 55.90 57.60 52.03 58.70 52.03 43.71
Cash Conversion Cycle (CCC)		 201.15 248.87 256.12 192.74 123.75 263.55 165.66 171.20 145.70 146.94 124.98
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 389 449 470 494 536 439 466 494 521 544 555
Invested Capital Turnover		 1.05 0.90 0.83 0.78 0.77 0.28 0.56 0.63 0.74 0.66 0.75
Increase / (Decrease) in Invested Capital		 64 60 21 24 42 -97 26 29 27 22 11
Enterprise Value (EV)		 2,224 1,985 1,442 1,160 1,241 1,106 1,164 1,052 1,069 1,593 2,206
Market Capitalization		 2,459 2,098 1,499 1,177 1,252 1,061 1,054 821 820 1,349 1,988
Book Value per Share		 $9.02 $8.41 $8.15 $8.18 $8.94 $6.69 $6.03 $4.71 $5.00 $5.68 $6.28
Tangible Book Value per Share		 $8.03 $7.37 $7.07 $7.02 $7.80 $5.58 $4.98 $3.18 $3.39 $4.02 $4.83
Total Capital		 706 654 629 637 661 770 656 593 598 644 706
Total Debt		 29 27 25 38 18 306 226 263 252 266 279
Total Long-Term Debt		 29 27 25 38 18 306 226 263 252 266 279
Net Debt		 -288 -177 -133 -105 -107 -25 35 165 176 166 127
Capital Expenditures (CapEx)		 43 15 24 13 7.42 0.70 3.59 8.42 6.49 8.43 8.17
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 36 64 61 18 148 30 162 167 43 -20 -20
Debt-free Net Working Capital (DFNWC)		 354 269 219 160 257 347 352 264 119 81 131
Net Working Capital (NWC)		 354 269 219 160 257 347 352 264 119 81 131
Net Nonoperating Expense (NNE)		 2.94 2.86 1.33 1.72 1.51 72 0.00 16 3.07 5.35 15
Net Nonoperating Obligations (NNO)		 -288 -177 -133 -105 -107 -25 35 165 176 166 127
Total Depreciation and Amortization (D&A)		 43 46 67 57 63 54 59 60 62 67 64
Debt-free, Cash-free Net Working Capital to Revenue		 9.70% 16.90% 15.95% 4.91% 37.30% 21.85% 63.55% 55.48% 11.42% -5.61% -4.80%
Debt-free Net Working Capital to Revenue		 94.63% 71.16% 57.64% 42.73% 64.97% 253.51% 137.98% 87.86% 31.74% 22.95% 32.05%
Net Working Capital to Revenue		 94.63% 71.16% 57.64% 42.73% 64.97% 253.51% 137.98% 87.86% 31.74% 22.95% 32.05%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.79 $0.43 $0.04 $0.36 $0.76 ($2.43) ($0.38) ($0.40) $0.47 $0.49 $0.65
Adjusted Weighted Average Basic Shares Outstanding		 69.69M 66.31M 64.90M 61.48M 61.36M 58.95M 58.58M 56.67M 54.31M 52.65M 53.64M
Adjusted Diluted Earnings per Share		 $0.78 $0.42 $0.04 $0.36 $0.76 ($2.43) ($0.38) ($0.40) $0.46 $0.48 $0.63
Adjusted Weighted Average Diluted Shares Outstanding		 69.69M 66.31M 64.90M 61.48M 61.36M 58.95M 58.58M 56.67M 55.15M 53.86M 55.54M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.76 ($2.43) ($0.38) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 69.69M 66.31M 64.90M 61.48M 61.36M 58.95M 58.58M 53.97M 52.95M 53.02M 53.99M
Normalized Net Operating Profit after Tax (NOPAT)		 68 42 34 52 61 -82 6.45 -0.25 38 41 67
Normalized NOPAT Margin		 18.24% 11.26% 8.98% 13.88% 15.35% -59.56% 2.53% -0.08% 10.23% 11.73% 16.43%
Pre Tax Income Margin		 23.30% 15.33% 7.88% 11.65% 19.04% -94.25% 4.31% -3.25% 12.30% 10.70% 15.43%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 53.43 26.90 15.92 15.32 21.89 -17.38 1.48 -0.75 6.97 5.18 3.68
NOPAT to Interest Expense		 40.67 18.88 7.13 12.11 17.02 -12.16 -1.35 -0.53 5.00 4.49 2.65
EBIT Less CapEx to Interest Expense		 27.38 20.06 3.49 10.74 19.79 -17.48 0.98 -2.06 6.07 4.18 3.33
NOPAT Less CapEx to Interest Expense		 14.63 12.04 -5.30 7.53 14.92 -12.26 -1.86 -1.84 4.10 3.50 2.29
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 14.72% 0.00% 0.00% 20.64% 7.48% -2.68% -51.05% -13.60% 4.35% 0.00% 0.00%
Augmented Payout Ratio		 92.91% 5.08% 368.59% 233.41% 44.74% -26.91% -301.28% -432.01% 85.51% 54.95% 3.19%

Quarterly Metrics And Ratios for IMAX

This table displays calculated financial ratios and metrics derived from IMAX's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 54,855,176.00 54,842,114.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 54,855,176.00 54,842,114.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 0.08 0.28
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -12.27% -9.00% -9.20% -11.98% 7.74% 9.53% 3.06% 16.62% 35.11% -6.10% 12.17%
EBITDA Growth		 -24.59% 8.96% -22.88% -16.74% 58.57% 16.12% 38.42% 29.75% 52.71% -20.02% 20.31%
EBIT Growth		 -63.66% 4.90% -80.46% -11.90% 247.28% 39.33% 399.51% 49.63% 153.41% -40.69% 44.81%
NOPAT Growth		 23.06% 5.93% 29.45% 9.59% 26.40% 42.92% -3.50% 40.47% 17.46% -19.49% 30.27%
Net Income Growth		 -18.87% 5.80% -47.23% 2.16% 107.37% 50.37% 141.18% 47.40% -63.22% -25.51% 30.02%
EPS Growth		 25.00% 50.00% -53.33% 18.18% 80.00% -33.33% 185.71% 42.31% -77.78% 75.00% 35.00%
Operating Cash Flow Growth		 -76.21% -151.69% 655.62% 22.71% 186.62% 163.38% -33.70% 91.35% 155.76% -42.04% 37.69%
Free Cash Flow Firm Growth		 11.61% -390.73% -51.15% -279.84% 30.13% 84.18% -13.25% 154.66% 85.74% 109.32% 166.85%
Invested Capital Growth		 5.48% 11.73% 7.43% 7.88% 4.30% 3.09% 7.40% 2.09% 2.08% 1.12% -0.12%
Revenue Q/Q Growth		 -17.21% -8.02% 12.43% 2.80% 1.33% -6.48% 5.79% 16.33% 17.40% -35.00% 26.37%
EBITDA Q/Q Growth		 -59.87% 64.61% -19.99% 57.51% -23.56% 20.54% -4.16% 46.94% -10.04% -36.87% 44.17%
EBIT Q/Q Growth		 -87.57% 336.66% -76.88% 602.03% -51.00% 75.19% -13.91% 102.46% -17.01% -58.99% 110.18%
NOPAT Q/Q Growth		 -59.53% -0.40% 119.02% 24.13% -53.32% 12.62% 47.88% 80.70% -60.97% -22.81% 139.27%
Net Income Q/Q Growth		 -77.95% 63.70% -6.40% 202.44% -55.25% 18.70% 50.12% 84.85% -88.84% 140.44% 162.03%
EPS Q/Q Growth		 -77.27% 20.00% 16.67% 271.43% -65.38% -55.56% 400.00% 85.00% -94.59% 250.00% 285.71%
Operating Cash Flow Q/Q Growth		 -86.06% -373.72% 419.46% 0.70% -67.45% -39.48% 234.20% 190.63% -56.49% -86.28% 693.87%
Free Cash Flow Firm Q/Q Growth		 -251.12% -146.78% 54.60% 3.45% 35.41% 44.13% -225.07% 146.60% -116.84% 136.54% 2,230.44%
Invested Capital Q/Q Growth		 4.26% 5.44% -2.83% 0.99% 0.80% 4.22% 1.24% -4.01% 0.79% 3.24% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 51.05% 59.26% 49.38% 55.79% 52.19% 61.36% 58.46% 63.07% 57.62% 56.29% 61.16%
EBITDA Margin		 19.50% 34.90% 24.84% 38.06% 28.71% 37.00% 33.52% 42.34% 32.45% 31.52% 35.96%
Operating Margin		 3.18% 15.25% 3.23% 21.23% 10.26% 19.31% 15.65% 27.23% 19.25% 12.23% 20.20%
EBIT Margin		 3.18% 15.12% 3.11% 21.23% 10.26% 19.23% 15.65% 27.23% 19.25% 12.15% 20.20%
Profit (Net Income) Margin		 3.85% 6.85% 5.70% 16.78% 7.41% 9.40% 13.34% 21.21% 2.02% 7.46% 15.47%
Tax Burden Percent		 226.63% 51.23% 471.47% 86.59% 82.48% 52.80% 91.08% 81.29% 38.23% 71.49% 81.94%
Interest Burden Percent		 53.34% 88.45% 38.92% 91.28% 87.51% 92.62% 93.64% 95.79% 27.40% 85.92% 93.46%
Effective Tax Rate		 -126.63% 48.77% -371.47% 13.41% 17.52% 47.20% 8.92% 18.71% 61.77% 28.51% 18.06%
Return on Invested Capital (ROIC)		 5.33% 5.50% 10.56% 12.22% 5.60% 6.57% 9.32% 15.34% 5.49% 6.21% 12.01%
ROIC Less NNEP Spread (ROIC-NNEP)		 3.62% 5.10% 5.74% 11.29% 5.02% 6.23% 8.86% 14.64% 0.93% 5.57% 11.24%
Return on Net Nonoperating Assets (RNNOA)		 1.83% 2.86% 2.96% 4.89% 2.37% 3.46% 4.27% 5.20% 0.34% 2.25% 3.83%
Return on Equity (ROE)		 7.15% 8.37% 13.52% 17.11% 7.97% 10.03% 13.59% 20.54% 5.83% 8.46% 15.84%
Cash Return on Invested Capital (CROIC)		 1.78% -4.07% -0.76% -0.83% 2.93% 4.19% 1.26% 7.73% 8.97% 9.36% 11.18%
Operating Return on Assets (OROA)		 1.46% 6.74% 1.35% 8.64% 4.40% 8.27% 6.69% 11.84% 9.16% 5.65% 9.41%
Return on Assets (ROA)		 1.76% 3.06% 2.48% 6.83% 3.17% 4.05% 5.70% 9.22% 0.96% 3.47% 7.21%
Return on Common Equity (ROCE)		 5.68% 6.56% 10.69% 13.60% 6.30% 7.80% 10.68% 16.31% 4.61% 6.61% 12.52%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 12.89% 10.79% 10.07% 0.00% 11.83% 13.29% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 6.21 6.18 14 17 7.85 8.84 13 24 9.22 7.11 17
NOPAT Margin		 7.22% 7.81% 15.22% 18.38% 8.47% 10.20% 14.25% 22.14% 7.36% 8.74% 16.55%
Net Nonoperating Expense Percent (NNEP)		 1.70% 0.41% 4.82% 0.93% 0.57% 0.34% 0.46% 0.70% 4.57% 0.64% 0.76%
Return On Investment Capital (ROIC_SIMPLE)		 1.04% - - - 1.22% 1.33% 1.91% 3.41% 1.31% 0.99% 2.32%
Cost of Revenue to Revenue		 48.95% 40.78% 50.62% 44.21% 47.77% 38.64% 41.54% 36.93% 42.38% 43.71% 38.84%
SG&A Expenses to Revenue		 40.77% 39.50% 42.23% 34.41% 34.98% 38.61% 38.50% 32.08% 28.33% 39.92% 33.57%
R&D to Revenue		 3.16% 2.76% 2.28% -0.29% 1.24% 1.52% 1.68% 1.41% 1.16% 2.22% 1.61%
Operating Expenses to Revenue		 47.86% 43.97% 46.15% 34.56% 41.96% 42.19% 42.82% 35.84% 38.27% 44.07% 40.96%
Earnings before Interest and Taxes (EBIT)		 2.74 12 2.77 19 9.51 17 14 29 24 9.88 21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 17 28 22 35 27 32 31 45 41 26 37
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.00 3.41 3.30 3.73 4.50 4.67 4.69 5.04 5.88 6.12 6.14
Price to Tangible Book Value (P/TBV)		 4.43 5.16 4.92 5.34 6.38 6.60 6.44 6.69 7.66 7.93 7.80
Price to Revenue (P/Rev)		 2.19 2.41 2.47 3.13 3.83 3.88 4.15 4.66 4.85 5.07 5.26
Price to Earnings (P/E)		 32.37 33.76 41.26 46.38 51.75 55.64 45.83 44.54 57.01 55.81 53.43
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 3.09% 2.96% 2.42% 2.16% 1.93% 1.80% 2.18% 2.25% 1.75% 1.79% 1.87%
Enterprise Value to Invested Capital (EV/IC)		 2.05 2.14 2.15 2.47 2.93 2.94 3.06 3.56 3.97 4.00 4.19
Enterprise Value to Revenue (EV/Rev)		 2.85 3.20 3.21 3.85 4.52 4.63 4.84 5.20 5.38 5.66 5.78
Enterprise Value to EBITDA (EV/EBITDA)		 9.48 10.21 10.59 13.11 14.31 14.38 14.13 14.58 14.84 16.10 16.19
Enterprise Value to EBIT (EV/EBIT)		 21.20 22.99 28.95 35.87 36.32 34.30 29.27 28.18 26.19 29.57 28.66
Enterprise Value to NOPAT (EV/NOPAT)		 29.57 32.17 34.84 37.95 41.87 41.19 37.73 36.74 36.41 38.35 37.91
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.23 44.42 20.23 21.00 22.49 18.75 22.82 17.98 17.36 18.45 18.09
Enterprise Value to Free Cash Flow (EV/FCFF)		 118.11 0.00 0.00 0.00 102.04 71.07 251.55 46.56 44.75 42.92 37.50
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.73 0.89 0.82 0.75 0.70 0.73 0.69 0.59 0.65 0.68 0.63
Long-Term Debt to Equity		 0.73 0.89 0.82 0.75 0.70 0.73 0.69 0.59 0.65 0.68 0.63
Financial Leverage		 0.50 0.56 0.52 0.43 0.47 0.56 0.48 0.36 0.36 0.40 0.34
Leverage Ratio		 2.42 2.47 2.41 2.34 2.27 2.33 2.27 2.16 2.14 2.14 2.09
Compound Leverage Factor		 1.29 2.18 0.94 2.14 1.99 2.16 2.12 2.07 0.59 1.84 1.95
Debt to Total Capital		 42.17% 47.15% 45.20% 42.90% 41.31% 42.12% 40.70% 37.07% 39.44% 40.44% 38.56%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 42.17% 47.15% 45.20% 42.90% 41.31% 42.12% 40.70% 37.07% 39.44% 40.44% 38.56%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 12.12% 11.82% 12.11% 12.16% 12.22% 12.77% 12.39% 12.56% 12.72% 12.91% 12.90%
Common Equity to Total Capital		 45.70% 41.02% 42.69% 44.94% 46.47% 45.11% 46.91% 50.37% 47.84% 46.65% 48.55%
Debt to EBITDA		 2.24 2.59 2.61 2.72 2.39 2.42 2.24 1.91 1.87 2.04 1.90
Net Debt to EBITDA		 1.56 1.88 1.76 1.69 1.49 1.58 1.36 0.85 0.86 1.02 0.83
Long-Term Debt to EBITDA		 2.24 2.59 2.61 2.72 2.39 2.42 2.24 1.91 1.87 2.04 1.90
Debt to NOPAT		 6.98 8.15 8.57 7.88 7.00 6.92 5.97 4.82 4.60 4.87 4.46
Net Debt to NOPAT		 4.87 5.93 5.80 4.90 4.35 4.52 3.63 2.14 2.10 2.43 1.94
Long-Term Debt to NOPAT		 6.98 8.15 8.57 7.88 7.00 6.92 5.97 4.82 4.60 4.87 4.46
Altman Z-Score		 1.19 1.47 1.15 1.48 1.91 2.05 2.23 2.66 2.91 2.97 3.19
Noncontrolling Interest Sharing Ratio		 20.56% 21.64% 20.96% 20.51% 20.89% 22.21% 21.45% 20.57% 20.92% 21.86% 20.95%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.87 3.31 1.39 1.41 1.47 2.25 2.44 1.68 1.75 1.90 1.90
Quick Ratio		 1.55 2.90 1.13 1.15 1.20 1.86 2.02 1.37 1.48 1.58 1.59
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -21 -52 -23 -23 -15 -8.15 -26 12 -2.08 0.76 18
Operating Cash Flow to CapEx		 101.44% -993.48% 2,209.21% 3,133.39% 249.02% 422.55% 983.91% 2,460.39% 2,072.97% 188.98% 152,309.52%
Free Cash Flow to Firm to Interest Expense		 -10.27 -26.49 -10.25 -9.62 -7.70 -4.53 -12.86 6.80 -0.12 0.40 8.73
Operating Cash Flow to Interest Expense		 1.97 -5.64 15.35 15.02 6.06 3.86 11.28 37.20 1.71 2.13 15.77
Operating Cash Flow Less CapEx to Interest Expense		 0.03 -6.21 14.66 14.54 3.63 2.95 10.13 35.69 1.63 1.00 15.76
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.46 0.45 0.44 0.41 0.43 0.43 0.43 0.43 0.48 0.47 0.47
Accounts Receivable Turnover		 2.75 2.78 2.90 2.76 2.89 2.74 2.92 3.39 3.80 3.51 3.45
Inventory Turnover		 5.09 4.29 4.34 3.91 5.03 4.81 4.20 3.93 5.02 4.92 4.42
Fixed Asset Turnover		 1.51 1.50 1.50 1.43 1.46 1.48 1.51 1.54 1.70 1.67 1.72
Accounts Payable Turnover		 6.22 7.09 7.37 5.09 7.02 7.46 6.04 6.40 8.35 7.86 6.19
Days Sales Outstanding (DSO)		 132.63 131.26 126.06 132.12 126.39 133.38 125.10 107.57 95.98 104.06 105.93
Days Inventory Outstanding (DIO)		 71.77 85.16 84.19 93.47 72.57 75.88 86.98 92.91 72.71 74.22 82.52
Days Payable Outstanding (DPO)		 58.70 51.48 49.50 71.77 52.03 48.96 60.45 57.01 43.71 46.43 58.93
Cash Conversion Cycle (CCC)		 145.70 164.94 160.75 153.81 146.94 160.30 151.62 143.47 124.98 131.85 129.52
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 521 550 534 540 544 567 574 551 555 573 573
Invested Capital Turnover		 0.74 0.70 0.69 0.66 0.66 0.64 0.65 0.69 0.75 0.71 0.73
Increase / (Decrease) in Invested Capital		 27 58 37 39 22 17 40 11 11 6.35 -0.69
Enterprise Value (EV)		 1,069 1,174 1,150 1,331 1,593 1,664 1,756 1,963 2,206 2,290 2,404
Market Capitalization		 820 883 882 1,080 1,349 1,397 1,503 1,761 1,988 2,052 2,187
Book Value per Share		 $5.00 $4.93 $5.08 $5.49 $5.68 $5.65 $5.96 $6.50 $6.28 $6.21 $6.49
Tangible Book Value per Share		 $3.39 $3.26 $3.41 $3.84 $4.02 $3.99 $4.34 $4.89 $4.83 $4.79 $5.11
Total Capital		 598 631 626 644 644 664 683 694 706 719 733
Total Debt		 252 297 283 276 266 280 278 257 279 291 283
Total Long-Term Debt		 252 297 283 276 266 280 278 257 279 291 283
Net Debt		 176 216 191 172 166 183 169 114 127 145 123
Capital Expenditures (CapEx)		 3.95 1.10 1.59 1.13 4.61 1.65 2.36 2.74 1.42 2.13 0.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 43 195 -18 -26 -20 50 60 -18 -20 -0.44 -4.17
Debt-free Net Working Capital (DFNWC)		 119 276 74 79 81 147 169 125 131 146 156
Net Working Capital (NWC)		 119 276 74 79 81 147 169 125 131 146 156
Net Nonoperating Expense (NNE)		 2.90 0.76 8.47 1.47 0.98 0.69 0.83 1.00 6.69 1.04 1.11
Net Nonoperating Obligations (NNO)		 176 216 191 172 166 183 169 114 127 145 123
Total Depreciation and Amortization (D&A)		 14 16 19 15 17 15 16 16 17 16 16
Debt-free, Cash-free Net Working Capital to Revenue		 11.42% 53.21% -5.01% -7.48% -5.61% 13.99% 16.49% -4.82% -4.80% -0.11% -1.00%
Debt-free Net Working Capital to Revenue		 31.74% 75.28% 20.56% 22.76% 22.95% 40.97% 46.63% 33.07% 32.05% 35.95% 37.43%
Net Working Capital to Revenue		 31.74% 75.28% 20.56% 22.76% 22.95% 40.97% 46.63% 33.07% 32.05% 35.95% 37.43%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.05 $0.06 $0.07 $0.26 $0.10 $0.04 $0.21 $0.38 $0.02 $0.08 $0.28
Adjusted Weighted Average Basic Shares Outstanding		 54.31M 52.50M 52.63M 52.68M 52.65M 53.15M 53.75M 53.79M 53.64M 54.13M 54.95M
Adjusted Diluted Earnings per Share		 $0.05 $0.06 $0.07 $0.26 $0.09 $0.04 $0.20 $0.37 $0.02 $0.07 $0.27
Adjusted Weighted Average Diluted Shares Outstanding		 55.15M 53.41M 53.43M 54.09M 53.86M 54.97M 55.16M 55.57M 55.54M 56.39M 56.57M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 52.95M 52.62M 52.68M 52.68M 53.02M 53.74M 53.78M 53.80M 53.99M 54.86M 54.84M
Normalized Net Operating Profit after Tax (NOPAT)		 3.03 6.18 2.01 17 11 8.87 14 24 18 7.11 19
Normalized NOPAT Margin		 3.53% 7.81% 2.26% 18.38% 11.80% 10.23% 15.03% 22.14% 14.39% 8.74% 18.38%
Pre Tax Income Margin		 1.70% 13.37% 1.21% 19.38% 8.98% 17.81% 14.65% 26.09% 5.27% 10.44% 18.88%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 1.35 6.15 1.21 8.26 5.02 9.25 6.96 16.00 1.40 5.21 10.24
NOPAT to Interest Expense		 3.05 3.18 5.93 7.16 4.14 4.91 6.34 13.01 0.54 3.75 8.39
EBIT Less CapEx to Interest Expense		 -0.60 5.58 0.52 7.78 2.59 8.34 5.82 14.49 1.32 4.09 10.23
NOPAT Less CapEx to Interest Expense		 1.11 2.61 5.24 6.68 1.71 3.99 5.20 11.50 0.45 2.63 8.38
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 4.35% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 85.51% 123.00% 142.00% 139.56% 54.95% 0.32% 3.11% 2.65% 3.19% 0.00% 29.15%

Financials Breakdown Chart

Key Financial Trends

IMAX’s latest statements show a meaningful improvement in operating performance. Second-quarter 2026 revenue reached $102.8 million, up approximately 12% from $91.7 million in the restated second quarter of 2025 and 15% from the first quarter of 2026. Gross margin improved to approximately 61.2%, compared with 58.5% a year earlier, while operating income rose to $20.8 million from $14.3 million.

Profitability also strengthened. Net income attributable to common shareholders increased to $15.4 million, or $0.27 per diluted share, from $11.3 million, or $0.20 per diluted share, in the year-ago quarter. The latest quarter included a $2.3 million restructuring charge, meaning reported operating results still absorbed some one-time costs.

Cash generation was solid in the second quarter. Operating cash flow increased to $32.0 million from $23.2 million year over year, although working-capital changes reduced cash flow by $10.0 million. Cash and equivalents rose to $159.9 million at June 30, 2026, from $109.3 million a year earlier and $146.0 million at the end of the first quarter.

  • Revenue growth has recovered: Quarterly revenue advanced from $68.8 million in Q3 2022 to $102.8 million in Q2 2026, with particularly strong results in Q3 and Q4 2025 and Q2 2026.
  • Margins are trending higher: Q2 2026 gross margin was approximately 61.2% and operating margin was approximately 20.2%, both above the comparable 2025 quarter.
  • Common-shareholder earnings improved: Diluted EPS rose to $0.27 in Q2 2026 from $0.20 in Q2 2025 and $0.07 in Q1 2026.
  • Operating cash flow remains positive: IMAX generated $32.0 million of operating cash flow in Q2 2026, following $29.4 million in Q4 2025 and $4.0 million in Q1 2026.
  • Liquidity has strengthened: Cash increased to $159.9 million, and current assets of $328.1 million exceeded current liabilities of $172.3 million by a wide margin.
  • Book equity has improved: Total common equity reached $355.9 million in Q2 2026, up from $320.4 million in Q2 2025, while accumulated retained losses narrowed from $261.3 million to $230.8 million.
  • Results remain seasonal: Revenue has ranged from $79.1 million to $125.2 million across the reported quarters, so individual-quarter comparisons may not fully reflect the company’s underlying annual trajectory.
  • Restatements affect comparisons: Several 2023–2025 income-statement and cash-flow periods were marked as restated, which investors should consider when comparing historical trends.
  • Debt remains significant: Long-term debt stood at $282.6 million, leaving approximately $122.7 million of debt net of cash. Interest expense was $2.0 million in Q2 2026.
  • Working capital can be a cash-flow drag: Changes in operating assets and liabilities reduced Q2 2026 operating cash flow by $10.0 million, continuing a pattern of volatile working-capital movements in recent quarters.

Overall, the statements point to improving revenue, margins, earnings and liquidity, supported by stronger recent operating cash flow. However, investors should continue to monitor the company’s sizable debt load, seasonal revenue pattern and working-capital volatility. The improvement is encouraging, but sustaining stronger results across multiple quarters will be important for confirming a durable uptrend.

09/01/26 01:14 AM ETAI Generated. May Contain Errors.

IMAX Financials - Frequently Asked Questions

According to the most recent income statement we have on file, IMAX's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

IMAX's net income appears to be on a downward trend, with a most recent value of $45.53 million in 2025, falling from $64.62 million in 2015. The previous period was $32.70 million in 2024. Find out what analysts predict for IMAX in the coming months.

IMAX's total operating income in 2025 was $84.23 million, based on the following breakdown:
  • Total Gross Profit: $246.19 million
  • Total Operating Expenses: $161.96 million

Over the last 10 years, IMAX's total revenue changed from $373.81 million in 2015 to $410.21 million in 2025, a change of 9.7%.

IMAX's total liabilities were at $466.30 million at the end of 2025, a 3.1% increase from 2024, and a 84.0% increase since 2015.

In the past 10 years, IMAX's cash and equivalents has ranged from $76.20 million in 2023 to $317.45 million in 2015, and is currently $151.17 million as of their latest financial filing in 2025.

Over the last 10 years, IMAX's book value per share changed from 9.02 in 2015 to 6.28 in 2025, a change of -30.3%.


Related Companies

Financial statements for NYSE:IMAX last updated on 7/23/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel